Volume 20, Number 12—December 2014
Dispatch
MERS Coronavirus Neutralizing Antibodies in Camels, Eastern Africa, 1983–1997
Table 2
Country, date | No. samples | mNT titer, no. (%) samples† |
||
---|---|---|---|---|
<80 | 80–800 | >800 | ||
Egypt, 1997 Jul | 43 | 9 (20.9) | 29 (67.4) | 5 (11.6) |
Somalia | ||||
1983 Jan–Nov | 25 | 8 (32.0) | 14 (56.0) | 3 (12.0) |
1984 Feb–Dec | 61 | 8 (13.1) | 45 (73.8) | 8 (13.1) |
Sudan, 1983 Jun | 60 | 11 (18.3) | 36 (60.0) | 13 (21.7) |
Total | 189 | 36 (19.0) | 124 (65.6) | 29 (15.3) |
*MERS-CoV, Middle East respiratory syndrome coronavirus; mNT, microneutralization test.
†mNT for MERS-CoV was done in a microtiter plate format in duplicate at dilutions 1:80 and 1:800. Serum with reciprocal titers >80 were considered MERS-CoV antibody positive.
1These authors contributed equally to this article.
Page created: November 19, 2014
Page updated: November 19, 2014
Page reviewed: November 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.